Boehringer Buys Antibody-Drug Conjugates Biotech NBE For €1.18bn

Second Acquisition In ROR1 Space In A Month

 
• By Kevin Grogan
  
Boehringer
NBE buy puts focus on Boehringer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business